Novel Integration of New prostate radiation therapy schedules with adJuvant Androgen deprivation

In men with intermediate and high-risk prostate cancer, the NINJA trial is looking at comparing two different radiotherapy treatment schedules called stereotactic body radiotherapy (SBRT). The aim is to develop better methods of treatment for prostate cancer using this type of treatment, and further understand what causes some of the side effects of treatments. It is hoped this research will potentially improve the accuracy and quality of radiotherapy treatment in prostate cancer.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Participating Centres

Accrual Target

472

Current Accrual

Trial Chairperson

Prof Jarad Martin, Calvary Mater Hospital, NSW, Australia
Dr Mark Sidhom, Liverpool Hospital, NSW, Australia

Trial Contact

ninjatrial@calvarymater.org.au

Clinical Trial Registration

Related Post

Prof Wee Loon Ong
24 September, 2025

Prostate Cancer Month: Focus on the TROG Genitourinary Working Party

To mark Prostate Cancer Month in September, we asked

24 September, 2025

TROG members and staff celebrate World Radiotherapy Awareness Day

LATEST NEWS: 24 September 2025 TROG Cancer Research staff